Dr. Shahryar Kavoussi is interviewed about the effectiveness of the breast cancer medication letrozole (Femara®) as compared with Clomid citrate (Clomid®) by KVUE ABC News’ Jim Bergamo. The interview highlights a recent study’s findings that, in women with Polycystic Ovary Syndrome (PCOS), letrozole more effectively induces ovulation and is associated with a higher live birth rate than Clomid citrate. The study was recently published in the New England Journal of Medicine by Legro et al. Watch the interview for more details.